Continual Reassessment Method vs. Traditional Empirically Based Design: Modifications Motivated by Phase I Trials in Pediatric Oncology by the Pediatric Brain Tumor Consortium
- 21 April 2009
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 19 (3) , 437-455
Abstract
In this article we provide additional support for the use of a model-based design in pediatric Phase I trials and present our modifications to the continual reassessment method (CRM), which were largely motivated by specific challenges we encountered in the context of the Pediatric Brain Tumor Consortium trials. We also summarize the results of our extensive simulations studying the operating characteristics of our modified approach and contrasting it to the empirically based traditional method (TM). Compared to the TM, our simulations indicate that the modified version of CRM is more accurate, exposes fewer patients to potentially toxic doses, and tends to require fewer patients. Further, the CRM-based MTD has a consistent definition across trials, which is important, especially in a consortium setting where multiple agents are being tested in studies that are often running simultaneously and accruing from the same patient population.Keywords
This publication has 21 references indexed in Scilit:
- Pediatric Phase I Trials in Oncology: An Analysis of Study Conduct EfficiencyJournal of Clinical Oncology, 2005
- Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development GroupAnnals of Oncology, 2004
- Continual reassessment designs with early terminationBiostatistics, 2002
- Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trialsBiostatistics, 2001
- Miscellanea. A stopping rule for the continual reassessment methodBiometrika, 1998
- IMPROVED DESIGNS FOR DOSE ESCALATION STUDIES USING PHARMACOKINETIC MEASUREMENTSStatistics in Medicine, 1996
- Consistency of continual reassessment method under model misspecificationBiometrika, 1996
- Some practical improvements in the continual reassessment method for phase I studiesStatistics in Medicine, 1995
- A comparison of two phase I trial designsStatistics in Medicine, 1994
- Quick Simultaneous Confidence Intervals for Multinomial ProportionsJournal of the American Statistical Association, 1987